Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2021 795 · FY2022 1,318 · FY2023 1,580 — 3-yr total 3,692
Limited public information available beyond the Reportal filing; appears to be a medical entity.
Group parent — controls 1 company · ownership
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| 5,690 | 6,168 | 8,390 | 13,495 | 12,542 | 15,718 | +22.5% | |
| Total COGS | 264 | 835 | 3,678 | 4,403 | 4,524 | 6,846 | +91.8% |
| Gross Profit | 5,427 | 5,333 | 4,712 | 9,092 | 8,019 | 8,872 | +10.3% |
| Gross Margin | 95.4% | 86.5% | 56.2% | 67.4% | 63.9% | 56.4% | |
| 3,537 | 3,599 | 1,516 | 3,302 | 3,179 | 3,687 | +0.8% | |
| EBITDA | 1,890 | 1,734 | 3,196 | 5,791 | 4,840 | 5,185 | +22.4% |
| EBITDA Margin | 33.2% | 28.1% | 38.1% | 42.9% | 38.6% | 33.0% | |
| Total D&A | 319 | 386 | 547 | 669 | 738 | 938 | +24.0% |
| Impairment (non-financial) | 0 | 0 | 0 | 63 | 85 | 67 | +3.0% |
| EBIT / Operating Income | 1,570 | 1,348 | 2,649 | 5,059 | 4,016 | 4,180 | +21.6% |
| Total Interest Income | 35 | 29 | 46 | 94 | 75 | 182 | +39.2% |
| Total Interest Expense | 11 | 90 | 130 | 135 | 112 | 81 | +48.2% |
| Total Other Income | 2 | 0 | 80 | 65 | 41 | 223 | nmf |
| Profit Before Tax | 1,592 | 1,287 | 2,645 | 5,083 | 4,020 | 4,503 | +23.1% |
| Total Income Tax | 269 | 69 | 84 | 149 | 226 | 291 | +1.6% |
| Net Profit / (Loss) | 1,322 | 1,218 | 2,515 | 4,841 | 3,719 | 4,030 | +25.0% |
| Net Margin | 23.2% | 19.7% | 30.0% | 35.9% | 29.6% | 25.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →